Methods for treating molluscum contagiosum warts include identifying a human with one or more molluscum contagiosum warts and applying an anti-infective composition to the one or more warts. The anti-infective composition comprises at least one anti-infective agent in a liquid carrier, such as an or
Methods for treating molluscum contagiosum warts include identifying a human with one or more molluscum contagiosum warts and applying an anti-infective composition to the one or more warts. The anti-infective composition comprises at least one anti-infective agent in a liquid carrier, such as an organohalide. The liquid carrier includes a tissue penetrating component for rapid penetration of the anti-infective agent into the one or more molluscum contagiosum warts. Application of the anti-infective composition to molluscum contagiosum warts causes the warts to turn black and/or fall off the skin in less than about 5 days.
대표청구항▼
1. A method of treating a molluscum contagiosum wart, comprising: identifying a human with a molluscum contagiosum wart on the skin, wherein the molluscum contagiosum wart is caused by molluscum contagiosum virus and comprises warty tissue and a nucleus inside the warty tissue containing viruses; to
1. A method of treating a molluscum contagiosum wart, comprising: identifying a human with a molluscum contagiosum wart on the skin, wherein the molluscum contagiosum wart is caused by molluscum contagiosum virus and comprises warty tissue and a nucleus inside the warty tissue containing viruses; topically applying an anti-infective composition to the molluscum contagiosum wart, the anti-infective composition comprising: at least one anti-infective agent in a liquid carrier,the anti-infective agent comprising an organohalide,the liquid carrier comprising a tissue penetrating solvent for rapid penetration of the anti-infective agent into the molluscum contagiosum wart; andcausing or allowing the anti-infective composition to penetrate into the molluscum contagiosum wart, including through the warty tissue and into the nucleus of the wart,the anti-infective composition killing viruses in the nucleus of the wart and causing the warty tissue to die and fall off the skin within 10 days or less;wherein the organohalide is selected from the group consisting of benzethonium halide, methyl benzethonium halide, cetyl pyridinium halide, chloroxylenol, hexachlorophene, triclosan, chlorhexidine, quaternary ammonium halide compounds having an alkyl with 6-18 carbons, ethoxynlated quaternary ammonium halides, alkyl benzyl dimethyl ammonium halide, alkyl dimethyl ethyl benzyl ammonium halide, n-dialkyl methyl benzyl ammonium halide, n-alkyl dimethyl benzyl ammonium halide, diisobutyl phenoxy ethoxy ethyl dimethyl benzyl ammonium halide, n-(C12C14C16) alkyl dimethyl benzyl ammonium chloride, dodecyl dimethyl ammonium halide, dioctyl dimethyl ammonium halide, dialkyl dimethyl ammonium halide, dialkyl methyl benzyl ammonium halide, octyl decyl dimethyl ammonium halide, lauryl dimethyl benzyl ammonium halide, o-benzyl-p-chlorophenol, dodecyl dimethyl ammonium halide, dioctyl dimethyl ammonium halide, and alkyl (C14C12C16) dimethyl benzyl ammonium halide. 2. The method of claim 1, wherein the at least one anti-infective agent comprises at least one quaternary ammonium chloride compound. 3. The method of claim 2, wherein the at least one quaternary ammonium chloride compound comprises benzalkonium chloride. 4. The method of claim 3, wherein the benzalkonium chloride is included in a concentration in a range from about 0.01% to about 0.5% by weight of the anti-infective composition. 5. The method of claim 3, wherein the benzalkonium chloride is included in a concentration in a range from about 0.05% to about 0.3% by weight of the anti-infective composition. 6. The method of claim 3, wherein the benzalkonium chloride is included in a concentration in a range from about 0.1% to about 0.2% by weight of the anti-infective composition. 7. The method of claim 3, wherein the benzalkonium chloride comprises benzalkonium chloride having an n-alkyl chain length that is at least one of C12, C14, C16, or C18. 8. The method of claim 1, wherein the anti-infective composition causes the one or more molluscum contagiosum warts to turn black and/or fall off the skin in 10 days or less. 9. The method of claim 1, wherein the anti-infective composition causes the one or more molluscum contagiosum warts to turn black and/or fall off the skin in 5 days or less. 10. The method of claim 1, wherein the anti-infective composition causes the one or more molluscum contagiosum warts to turn black and/or fall off the skin in 3 days or less. 11. The method of claim 1, wherein the tissue penetrating solvent comprises isopropyl alcohol and water, the isopropyl alcohol comprising from about 50% to about 80% by volume of the tissue penetrating solvent. 12. The method of claim 1, wherein the anti-infective composition further comprises a topical anesthetic. 13. The method of claim 12, wherein the topical anesthetic is included in an amount so as to enhance penetration of the anti-infective composition into the one or more molluscum contagiosum warts. 14. The method of claim 12, wherein the topical anesthetic comprises benzocaine. 15. The method of claim 1, wherein the anti-infective composition is not visibly detectable on the one or more molluscum contagiosum warts within about 1 minute or less after application. 16. The method of claim 1, wherein the anti-infective composition contains less than 10% of oils. 17. The method of claim 1, wherein the anti-infective composition contains less than 10% of tea tree oil. 18. A method of treating a molluscum contagiosum wart, comprising: identifying a human with a molluscum contagiosum wart on the skin, wherein the molluscum contagiosum wart is caused by molluscum contagiosum virus and comprises warty tissue and a nucleus inside the warty tissue containing viruses;applying an anti-infective composition to the molluscum contagiosum wart while applying pressure to or agitating the warty tissue to aid the anti-infective composition in penetrating into the warty tissue, the anti-infective composition comprising: at least one quaternary ammonium halide in a liquid carrier,the liquid carrier comprising a tissue penetrating solvent selected from methanol, ethanol, isopropyl alcohol, or acetone for rapid penetration of the anti-infective agent into the molluscum contagiosum wart so that the anti-infective composition has a viscosity that is not significantly greater than that of water and so that the anti-infective composition is not visibly detectable on the molluscum contagiosum wart within about 1 minute or less after application; andcausing or allowing the anti-infective composition to penetrate into the molluscum contagiosum wart, including through the warty tissue and into the nucleus of the wart,the anti-infective composition killing viruses in the nucleus of the wart and causing the warty tissue to die and eventually fall off the skin. 19. A method of treating a molluscum contagiosum wart, comprising: identifying a human with a molluscum contagiosum wart on the skin, wherein the molluscum contagiosum wart is caused by molluscum contagiosum virus and comprises warty tissue and a nucleus inside the warty tissue containing viruses;applying an anti-infective composition to the molluscum contagiosum wart while applying pressure to or agitating the warty tissue to aid the anti-infective composition in penetrating into the warty tissue, the anti-infective composition comprising: at least one benzalkonium chloride compound in a liquid carrier,the liquid carrier comprising a tissue penetrating component for rapid penetration of the anti-infective agent into the molluscum contagiosum wart and containing less than 10% oil; andcausing or allowing the anti-infective composition to penetrate into the molluscum contagiosum wart, including through the warty tissue and into the nucleus of the wart,the anti-infective composition killing viruses in the nucleus of the wart and causing the warty tissue to die and fall off the skin in 10 days or less.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (117)
Gern James E. ; Mosser Anne G., Acidic buffered nasal spray.
Kimberly Ann Biedermann ; Jeffrey Michael Morgan ; Karl Shiqing Wei ; Mark Richard Sine GB; Cheyne P. Thomas ; David Edmund Tarantino ; Christopher Irwin ; Christopher Dean Putman ; Peter Wil, Antimicrobial cleansing compositions containing 2-pyrrolidone-5-carboxylic acid.
Gorman William G. (East Greenbush NY) Popp Karl F. (Schodack Landing NY), Basic amino or ammonium antimicrobial agent-polyethylene glycol ester surfactant-betaine and/or amine oxide surfactant c.
Donofrio Deborah K. (The Woodlands TX) Whitekettle Wilson K. (Conroe TX), Biocidal compositions and use thereof containing a synergistic mixute of 2-(decylthio)ethanamine hydrochloride and n-alk.
Swered Paul (Philadelphia PA) Donofrio Deborah K. (The Woodlands TX), Biocidal compositions and use thereof employing a synergistic mixture of n-alkyldimethyl benzyl ammonium halide and n-do.
Dalrymple Damon M. ; Manning Monna ; Merz Frank,DEX, Clear personal care formulations containing quaternary ammonium compounds and other nitrogen-containing compounds.
Dalrymple, Damon M.; Manning, Mona; Merz, Frank, Clear personal care formulations containing quaternary ammonium compounds and other nitrogen-containing compounds.
Balzarini Jan M. R. (Heverlee BEX) De Clercq Erik D. A. (Heverlee BEX), Combinations of TS-inhibitors and viral TK-inhibitors in antiherpetic medicines.
Bergeron Michel G.,CAX ; Desormeaux Andre,CAX ; Tremblay Michel,CAX, Formulation for use in the prevention of pathogen induced diseases including HIV and HSV.
Drube Clairmont G. (Green Valley AZ), Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds fo.
Simmons Paul L. (6250 Kipps Colony Ct. ; No. 203 Gulfport FL 33707) Immekus Robert L. (106 E. Hanna Ave. Tampa FL 33604), Method of immersion sterilization and organic cold chemical sterilant.
Stalcup Robert W. (21152 Pepopertree La. Mission Viejo CA 92691) McCall Robert G. (7468 E. Raintree Ct. Scottsdale AZ 85258), Method of providing topoical anesthetic in a sanitary and convenient manner.
Bourbon Pierre (Toulouse FRX) Lagny Pierre (Clebridge IEX) Billot Pierre (Neuilly Sur Seine FRX), Method which inhibits or destroys at least one unicellular living organism containing a quaternary ammonium fluoride.
Stevens Kent R. (Chatam NJ) Taggart William V. (Quakertown NJ), Polyamides bearing functionalized side chains useful as water soluble hypolipidemic agents.
Bollen Alex (Gaasbeekstraat 65 Brussels BEX) Moguilevsky Nicle (4 rue P. Delacroix Brussels B-1150 BEX) Pourtois Michel (23 avenue de la Floride Brussels BEX), Prophylactic and therapeutic applications of peroxidases.
Sheldon Bernard G. (Palo Alto CA) Wingard ; Jr. Robert E. (Mountain View CA) Weinshenker Ned M. (Palo Alto CA) Dawson Daniel J. (Los Altos CA), Quaternary ammonium group-containing polymers having antimicrobial activity.
Brown-Skrobot Susan K. (Hamilton Square NJ) Hossain Shafi U. (Roswell GA) Smith Kenneth R. (Marietta GA) Kuenn Cary K. (Appleton WI), Virucidal composition, the method of use and the product therefor.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.